ENTRY       D12150                      Drug
NAME        Elivaldogene autotemcel (USAN/INN);
            Skysona (TN)
PRODUCT     SKYSONA (bluebird bio)
REMARK      ATC code: A16AX21
            Product: D12150<US>
EFFICACY    Methabolic disease therapeutic agent (perosisomal disease)
  DISEASE   Cerebral adrenoleukodystrophy [DS:H00176]
  TYPE      Cellular therapy product
COMMENT     Treatment of cerebral adrenoleukodystrophy
TARGET      ABCD1 (ALDP) [HSA:215] [KO:K05675]
  PATHWAY   hsa02010(215)  ABC transporters
            hsa04146(215)  Peroxisome
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             A ALIMENTARY TRACT AND METABOLISM
              A16 OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
               A16A OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
                A16AX Various alimentary tract and metabolism products
                 A16AX21 Elivaldogene autotemcel
                  D12150  Elivaldogene autotemcel (USAN/INN) &lt;US&gt;
            Target-based classification of drugs [BR:br08310]
             Transporters
              ABC transporters
               ABCD (ALD) subfamily
                ABCD1 (ALDP)
                 D12150  Elivaldogene autotemcel (USAN/INN) &lt;US&gt;
            New drug approvals in the USA [br08319.html]
             Cellular and gene therapy products
              D12150
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D12150
             Cellular and gene therapy products
              D12150
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D12150
///
